Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Transplantation

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/TP.0000000000001293PMID 27362316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma

  2016cited by this paper
• High preoperative bilirubin values protect against reperfusion injury after live donor liver transplantation

  2015cited by this paper
• Microsteatosis may not interact with macrosteatosis in living donor liver transplantation.

  2015cited by this paper
• Effect of pure microsteatosis on transplant outcomes after living donor liver transplantation: A matched case‐control study

  2014cited by this paper
• Genetic variation underlying common hereditary hyperbilirubinaemia (Gilbert's syndrome) and respiratory health in the 1946 British birth cohort.

  2014cited by this paper
• Liver transplantation using grafts of living donors with isolated unconjugated hyperbilirubinemia: a matched case–control study

  2013cited by this paper
• Serum C‐reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma

  2012cited by this paper
• Effects of unconjugated bilirubin on chromosomal damage in individuals with Gilbert's syndrome measured with the micronucleus cytome assay.

  2012cited by this paper
• Are propensity scores really superior to standard multivariable analysis?

  2011cited by this paper
• Association of Serum Total Bilirubin with Serum High Sensitivity C-reactive Protein in Middle-aged Men

  2011cited by this paper
• Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women.

  2010cited by this paper
• Gilbert-Meulengracht’s syndrome and pharmacogenetics: is jaundice just the tip of the iceberg?

  2010cited by this paper
• Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome).

  2010cited by this paper
• Complement activation and disease: protective effects of hyperbilirubinaemia.

  2009cited by this paper
• Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.

  2009cited by this paper
• Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents.

  2009cited by this paper
• Prognostic Models With Competing Risks: Methods and Application to Coronary Risk Prediction

  2009cited by this paper
• Cumulative Incidence in Competing Risks Data and Competing Risks Regression Analysis

  2007cited by this paper
• Bilirubin Inhibits Tumor Cell Growth via Activation of ERK

  2007cited by this paper
• Therapeutic Applications of Bilirubin and Biliverdin in Transplantation

  2007cited by this paper
• Products of heme oxygenase and their potential therapeutic applications.

  2006cited by this paper
• Serum bilirubin levels in the U.S. Population: Gender effect and inverse correlation with colorectal cancer

  2004cited by this paper
• A note on competing risks in survival data analysis

  2004cited by this paper
• Serum levels of micronutrients, antioxidants and total antioxidant status predict risk of breast cancer in a case control study.

  2002cited by this paper
• Serum bilirubin and 10-year mortality risk in a Belgian population

  2001cited by this paper
• Donor liver uridine diphosphate (UDP)-glucuronosyltransferase-1A1 deficiency causing Gilbert's syndrome in liver transplant recipients.

  2000cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper
• Persistent unconjugated hyperbilirubinemia after liver transplantation due to an abnormal bilirubin UDP-glucuronosyltransferase gene promoter sequence in the donor.

  1997cited by this paper
• Persistent unconjugated hyperbilirubinemia after liver transplantation due to an abnormal bilirubin UDP-glucuronosyltransferase gene promotor sequence in the donor

  1997cited by this paper
• Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

  1996cited by this paper
• Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins.

  1996cited by this paper
• Proportional hazards tests and diagnostics based on weighted residuals

  1994cited by this paper
• A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin.

  1993cited by this paper
• Bilirubin is an antioxidant of possible physiological importance.

  1987cited by this paper

• The Age-Male-Albumin-Bilirubin-Platelet Risk Score Predicts Postoperative Prognosis of Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Study.

  2025cites this paper
• The Protective Role of the Heme Catabolic Pathway in Hepatic Disorders

  2021cites this paper
• Therapeutic application and construction of bilirubin incorporated nanoparticles.

  2020cites this paper
• Decrease in the Risk of Post-Transplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells.

  2020cites this paper
• Patient selection in liver transplantation for hepatocellular carcinoma

  2020cites this paper
• Postoperative adjuvant TACE-associated nomogram for predicting the prognosis of resectable Hepatocellular Carcinoma with portal vein Tumor Thrombus after Liver Resection

  2020cites this paper
• Biliverdin reductase and bilirubin in hepatic disease.

  2018cites this paper
• Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation

  2018cites this paper
• Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf

  2017cites this paper